Related Experiment Video
Updated: Aug 7, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Paraoxonase activity and genotype predispose to successful aging
Francesca Marchegiani1, Maurizio Marra, Liana Spazzafumo
1Center of Molecular Biology and Genetics, INRCA, Ancona, Italy. b.molecolare@inrca.it
The paraoxonase 1 (PON1) R allele is linked to higher enzyme activity and longevity. This genetic influence on PON1 activity persists throughout life, even in centenarians, suggesting a role in extreme aging.
Area of Science:
- Genetics
- Biochemistry
- Gerontology
Background:
- The paraoxonase 1 (PON1) codon 192 R allele is associated with successful aging.
- Understanding the interplay between PON1 genotypes, activity, and aging is crucial for gerontological research.
Purpose of the Study:
- To investigate the relationship between PON1 genotypes, enzymatic activity, and mass concentration across a wide age range.
- To specifically examine these relationships in nonagenarian and centenarian participants to understand longevity.
- To determine if PON1 genetic variability influences paraoxonase activity and contributes to the longevity phenotype.
Main Methods:
- Evaluated PON1 genotypes, enzymatic activity, and mass concentration in 229 participants aged 22-104.
- Focused analysis on nonagenarian and centenarian subgroups.
- Employed multinomial regression logistic models to assess the contribution of PON1 parameters to longevity.
Main Results:
- Found genetic control of paraoxonase activity, maintained throughout life, including in extreme age groups.
- Observed a significant decrease in paraoxonase activity with aging.
- Identified significantly higher paraoxonase activity in R+ and M- carriers compared to other genotypes.
- Demonstrated that paraoxonase activity and specific PON1 genotypes (R+ and M-) significantly explain the longevity phenotype.
Conclusions:
- Genetic variability at the PON1 locus significantly influences paraoxonase activity across the lifespan.
- Both PON1 genetic variability and resulting paraoxonase activity levels appear to be important factors in survival at extreme advanced ages.
- The study supports a role for PON1 in the aging process and longevity.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
09:38Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion